
Biointron is excited to announce our participation in BioPlus-Interphex Korea 2025, taking place October 15-17, 2025, in Seoul, South Korea. This premier event brings together leaders in biotechnology, pharmaceuticals, and healthcare to showcase innovations, discuss industry trends, and foster collaboration across the life sciences sector.
At the event, Biointron will highlight our expertise in the antibody field. Attendees are invited to visit our booth to learn how our cutting-edge solutions are driving advancements in drug discovery, therapeutic development, and precision medicine.
We look forward to engaging with industry professionals, exchanging ideas, and exploring opportunities for collaboration. Join Biointron at BioPlus-Interphex Korea 2025 as we work together to advance biotechnology and improve healthcare outcomes worldwide.
For more details about the event, please visit the BioPlus-Interphex Korea 2025 website [https://www.bioplusinterphex.co.kr/en-us.html]
Time: October 15-17, 2025
Location: COEX Seoul | Seoul, Korea
Booth: #TBD
Time: April 28 – 30, 2026
Location: Seoul, South Korea
Booth: #B31
Time: April 15 - 19, 2026
Location: Boston, MA
Booth: #1228
Time: May 26 - 27, 2026
Location: Taipei, Taiwan
Time: May 9 - 10, 2026
Location: Boston, MA
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.



